- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT05354271
High-intensity Interval Training in Patients With Atrial Fibrillation (HIIT-AF)
Impact of High-intensity Interval Training in Patients With Atrial Fibrillation: Understanding of the Underlying Cardiovascular Mechanisms
A key characteristic of the heart is its regular rhythm. When the heart is exposed to irregular electric impulses, such as with atrial fibrillation (AF), detrimental effects can occur affecting the ability of the heart to pump blood. AF affects more than 33 million individuals worldwide, and places individuals at increased risk for stroke, heart failure and death. Of note, being fit seems to protect the long-term severity of AF, and individuals with AF who improved their aerobic fitness seem to decrease their severity of atrial fibrillation. Although exercise training is known to improve aerobic fitness, there are limited data investigating the benefits of an exercise training program on the reduction of AF burden.
Once AF is present, regular exercise in these patients reduces the risk for developing cardiovascular events. Moreover, exercise training at high-intensity seems to bring greater adaptations in cardiac patients. This effect may be related to improvements in cardiovascular function and structure. No previous study has explored this possibility in patients with AF. Therefore, I will assess cardiac function and blood vessel quality before and after exercise training (at high- and moderate-intensities) in patients with AF. Better insight into how intensity of exercise training could affect the heart and the blood vessels can lead to better exercise recommendations in this population.
This project will contribute to improved clinical care for patients with AF, specifically related to the prescription of the optimal dose and type of exercise. This may result in fewer complications, improved quality of life, and lower socio-economic/healthcare costs.
Study Overview
Status
Conditions
Intervention / Treatment
Detailed Description
Atrial fibrillation (AF) is the most common clinically significant arrhythmia, affecting more than 33 million individuals worldwide. AF leads to structural and electrical remodeling in both the atria and ventricles and is strongly related to an increased risk of stroke, heart failure and death. The CARDIO-FIT study demonstrated that AF patients with a higher baseline aerobic fitness were almost 3 times more likely to maintain arrhythmia freedom after a 4-year follow-up; also, AF patients who gained more than 2 metabolic equivalents (METs, aerobic fitness) were more than two-fold more likely to maintain sinus rhythm.
High-intensity exercise training and atrial fibrillation. Each METs gained was associated with a 9% decline in the risk of arrhythmia recurrence. From studies performed in patients with cardiovascular disease, high-intensity interval training (HIIT) seems to bring at least similar or greater improvements in aerobic fitness compared to a moderate-intensity continuous training (MICT). Moreover, in patients with AF, time in AF was reduced of -3.3±7.2% after 12 weeks of HIIT compared to an increased time in AF of 4.2±11.8% in a control group without exercise. Whilst this highlights the potency of HIIT, no previous study has directly compared the effects of HIIT vs. MICT in AF patients on AF burden.
Cardiovascular physiological mechanism(s). Patients with AF exhibit cardiac and vascular dysfunction. However, exercise training improves cardiac and vascular function in human, but the effects are unknown in AF patients. This knowledge is important to improve management of patients with AF with an optimal training prescription. Research on long-term effects and safety related to high-intensity exercise in AF patients is therefore warranted. The findings of the optimal training prescription will help us to update and improve the current guidelines.
Building on the latest scientific insights, the overall aim of this proposal is to determine the optimal intensity for reducing the AF burden. Moreover, the understanding of the underlying mechanisms could help us to determine the cardiovascular adaptations related to exercise training (HIIT or MICT).
Taken together, this study will answer these two questions:
- What is the best exercise intensity for reducing the time in AF?
- What are the underlying cardiovascular mechanisms associated with any training related decrease in AF burden? Objectives. Objective 1. High-intensity interval training and AF: The investigators will compare the effects of HIIT and MICT on the burden of AF to test the hypothesis that HIIT decreases the time in AF to a greater extent than MICT.
Objective 2. Cardiovascular physiological mechanisms: The investigators will assess cardiovascular function in all AF patients before and after the training intervention, to test the hypothesis that HIIT is associated with greater cardiovascular adaptation compared to MICT.
Methods. Experimental design: The investigators will perform a 3-arm randomised controlled trial to answer the first research question. The investigators will compare regular care (control group) with regular care + HIIT and regular care + MICT in a total of 60 stable outpatients with non-permanent AF in need for rhythm control (catheter ablation or cardioversion) on the pre-procedure burden of AF, and post-procedure recurrence. When participants are listed on the waiting list for the ablation procedure, they will be assigned to control or HIIT or MICT in a randomized order. The waiting list is approximately 3 months, so patients would have the exercise program for at least 3 months prior to the rhythm control procedure, and continue for 3 months post-procedure to assess AF recurrence. To answer the second research question, the investigators will perform cardiac and vascular functions measurements at baseline, 3 months, and 6 months training intervention in all patients.
Study Type
Enrollment (Anticipated)
Phase
- Not Applicable
Contacts and Locations
Study Locations
-
-
Merseyside
-
Liverpool, Merseyside, United Kingdom, L14 3PE
- Recruiting
- Liverpool Centre for Cardiovascular Sciences
-
Contact:
- Maxime Boidin, PhD
- Phone Number: 1223 0151 600 1223
- Email: maxime.boidin@lhch.nhs.uk
-
-
Participation Criteria
Eligibility Criteria
Ages Eligible for Study
Accepts Healthy Volunteers
Genders Eligible for Study
Description
Inclusion Criteria:
- Presence of non-permanent AF
- > 18 years old
Exclusion Criteria:
- Performing endurance training at high intensity >2 times/week or at moderate intensity >3 times/week;
- Previous cardiac surgery not related to AF;
- LVEF <45%;
- Severe coronary artery disease non-suitable for revascularization;
- Significant cardiac valve disease;
- Implanted cardiac pacemaker;
- And restriction to cardiopulmonary exercise testing or severe intolerance to exercise.
Study Plan
How is the study designed?
Design Details
- Primary Purpose: Prevention
- Allocation: Randomized
- Interventional Model: Parallel Assignment
- Masking: Double
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
---|---|
Experimental: High-intensity interval training
Patients will cycle or walk/run four intervals of four-min at high intensity with the aim to reach 80-90% of peak oxygen consumption, 90-95% of peak heart rate, 15-17 Borg scale, shortness of breath).
Each interval is separated by a three-min active recovery, at 50-60% of peak oxygen consumption or 70-75% of peak heart rate.
Total exercise time will be 38 min including the warm-up and cool-down.
|
Patients will cycle or walk/run four intervals of four-min at high intensity with the aim to reach 80-90% of peak oxygen consumption, 90-95% of peak heart rate, 15-17 Borg scale, shortness of breath).
Each interval is separated by a three-min active recovery, at 50-60% of peak oxygen consumption or 70-75% of peak heart rate.
Total exercise time will be 38 min including the warm-up and cool-down.
|
Active Comparator: Moderate-intensity continuous training
Patients will cycle or walk/run continuously at moderate intensity (50-60% of peak oxygen consumption, 70-75% of peak heart rate) for 37 min.
Total exercise time will be 47 min for the moderate-intensity continuous training group including warm-up and cool-down (isoenergetic compared to high-intensity interval training).
|
Patients will cycle or walk/run continuously at moderate intensity (50-60% of peak oxygen consumption, 70-75% of peak heart rate) for 37 min.
Total exercise time will be 47 min for the Moderate-intensity continuous training group including warm-up and cool-down (isoenergetic compared to high-intensity interval training).
|
No Intervention: Control
The control group will continue their habits without increasing the level of physical activity nor participate to any supervised exercise training.
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
Change in burden of atrial fibrillation
Time Frame: baseline and 3 months post rhythm control procedure
|
Burden of atrial fibrillation (number of episodes) continually measured, and reported by the patient.
Measured by Huawei Band 4 and 6
|
baseline and 3 months post rhythm control procedure
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
Maximal oxygen uptake
Time Frame: baseline and 3 months post rhythm control procedure
|
VO2peak
|
baseline and 3 months post rhythm control procedure
|
Peripheral endothelial function
Time Frame: baseline and 3 months post rhythm control procedure
|
FMD
|
baseline and 3 months post rhythm control procedure
|
Carotid structure
Time Frame: baseline and 3 months post rhythm control procedure
|
IMT
|
baseline and 3 months post rhythm control procedure
|
Central endothelial function
Time Frame: baseline and 3 months post rhythm control procedure
|
CAR
|
baseline and 3 months post rhythm control procedure
|
Health related quality of life
Time Frame: baseline and 3 months post rhythm control procedure
|
Measured with the Medical Outcome Survey Short Form-36 (SF-36) questionnaire
|
baseline and 3 months post rhythm control procedure
|
Health related quality of life
Time Frame: baseline and 3 months post rhythm control procedure
|
Measured with the Atrial Fibrillation Effect on Quality of Life (AFEQT) questionnaire
|
baseline and 3 months post rhythm control procedure
|
Health related quality of life
Time Frame: baseline and 3 months post rhythm control procedure
|
Measured with the modified Mayo AF-Specific Symptom Inventory (mMAFSI) questionnaire
|
baseline and 3 months post rhythm control procedure
|
Health related quality of life
Time Frame: baseline and 3 months post rhythm control procedure
|
Measured with the HeartQoL questionnaire
|
baseline and 3 months post rhythm control procedure
|
Physical activity level
Time Frame: baseline and 3 months post rhythm control procedure
|
Steps, sedentary time, light (< 3 METs), moderate (3-<6 METs) and vigorous (≥6 METS) physical activities, measured with the Huawei bands for 14 nights and days (24h)
|
baseline and 3 months post rhythm control procedure
|
Resting atrial and ventricular function
Time Frame: baseline and 3 months post rhythm control procedure
|
Atrial and ventricular function including left ventricular function, volume, dimension of the cavities, wall thickness, blood and tissue velocities measured by echocardiography
|
baseline and 3 months post rhythm control procedure
|
Myocardial strain
Time Frame: baseline and 3 months post rhythm control procedure
|
GLS, circumferential and radial strain measured by echocardiography
|
baseline and 3 months post rhythm control procedure
|
Strain-area loop
Time Frame: baseline and 3 months post rhythm control procedure
|
Relation between changes in volume and strain measured by echocardiography
|
baseline and 3 months post rhythm control procedure
|
Atrial and ventricular function during exercise
Time Frame: baseline and 3 months post rhythm control procedure
|
Atrial and ventricular function including left ventricular function, volume, dimension of the cavities, wall thickness, blood and tissue velocities measured by echocardiography during exercise
|
baseline and 3 months post rhythm control procedure
|
Collaborators and Investigators
Study record dates
Study Major Dates
Study Start (Actual)
Primary Completion (Anticipated)
Study Completion (Anticipated)
Study Registration Dates
First Submitted
First Submitted That Met QC Criteria
First Posted (Actual)
Study Record Updates
Last Update Posted (Actual)
Last Update Submitted That Met QC Criteria
Last Verified
More Information
Terms related to this study
Keywords
Additional Relevant MeSH Terms
Other Study ID Numbers
- 21LJMUSPONSOR060
Plan for Individual participant data (IPD)
Plan to Share Individual Participant Data (IPD)?
IPD Plan Description
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
Studies a U.S. FDA-regulated device product
product manufactured in and exported from the U.S.
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Atrial Fibrillation
-
Ablacon, Inc.CompletedArrhythmias, Cardiac | Atrial Fibrillation, Persistent | Persistent Atrial Fibrillation | Longstanding Persistent Atrial FibrillationGermany
-
Ablacon, Inc.RecruitingAtrial Fibrillation | Arrhythmias, Cardiac | Arrhythmia | Atrial Flutter | Atrial Fibrillation, Persistent | Atrial Tachycardia | Atrial Arrhythmia | Atrial Fibrillation Paroxysmal | Atrial Fibrillation, Paroxysmal or PersistentUnited States, Belgium, Netherlands, Czechia
-
Barts & The London NHS TrustAtriCure, Inc.Not yet recruitingAtrial Fibrillation, Persistent | Persistent Atrial Fibrillation | Atrial Arrhythmia | Atrium; FibrillationUnited Kingdom
-
AtriCure, Inc.Active, not recruitingPersistent Atrial Fibrillation | Atrial Fibrillation (AF) | Longstanding Persistent Atrial FibrillationUnited States
-
Maastricht University Medical CenterRWTH Aachen UniversityUnknownAtrial Fibrillation (Paroxysmal) | Atrial Fibrillation Recurrent | Atrial Fibrillation Common Gene VariantsNetherlands
-
Adagio MedicalRecruitingAtrial Fibrillation | Atrial Flutter | Paroxysmal Atrial Fibrillation | Persistent Atrial FibrillationNetherlands, Germany, Belgium
-
Vivek ReddyEnrolling by invitationAtrial Fibrillation and Flutter | Atrial Flutter Typical | Atrial Fibrillation, Paroxysmal or PersistentUnited States
-
Fundació Institut de Recerca de l'Hospital de la...RecruitingAtrial Arrhythmia | Atrial Fibrillation and Flutter | Atrial Fibrillation RecurrentSpain
-
Beijing Anzhen HospitalJohnson & Johnson; Heart Health Research CenterNot yet recruitingParoxysmal Atrial Fibrillation | Persistent Atrial Fibrillation
-
Maastricht UniversityRadboud University Medical Center; Maastricht University Medical CenterRecruitingAtrial Fibrillation | Atrial Fibrillation, Persistent | Atrial Fibrillation ParoxysmalNetherlands
Clinical Trials on High-intensity interval training
-
University of MichiganCompletedGlucose IntoleranceUnited States
-
Universidad SurcolombianaMaciste Macias; Gilberto AstaizaRecruiting
-
Kuopio Research Institute of Exercise MedicineKuopio University Hospital; University of Basel; University of Eastern Finland; Social Insurance Institution, FinlandTerminatedUnstable Angina Pectoris | Acute Myocardial Infarction | Recurrent Myocardial InfarctionFinland
-
Cairo UniversityKasr El Aini HospitalCompletedDiabetes Mellitus, Type 2Egypt
-
Universidad Santo TomasCompletedMetabolic DiseasesColombia
-
Norwegian University of Science and TechnologySt. Olavs Hospital; Liverpool John Moores University; Australian Catholic UniversityCompletedPolycystic Ovary SyndromeAustralia, Norway
-
Norwegian University of Science and TechnologySt. Olavs Hospital; Liverpool John Moores University; Australian Catholic UniversityCompletedPolycystic Ovary SyndromeAustralia, Norway
-
Hunter College of City University of New YorkRecruiting
-
Université de SherbrookeRecruiting
-
Riphah International UniversityCompleted